- Home
- NNNN vs JELD Comparison
NNNN vs JELD Comparison
Compare NNNN & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- JELD
- Stock Information
- Founded
- NNNN 2021
- JELD 1960
- Country
- NNNN Germany
- JELD United States
- Employees
- NNNN N/A
- JELD N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- JELD Forest Products
- Sector
- NNNN Health Care
- JELD Basic Materials
- Exchange
- NNNN Nasdaq
- JELD Nasdaq
- Market Cap
- NNNN 369.6M
- JELD 326.7M
- IPO Year
- NNNN 2025
- JELD 2017
- Fundamental
- Price
- NNNN $16.10
- JELD $3.62
- Analyst Decision
- NNNN
- JELD Hold
- Analyst Count
- NNNN 0
- JELD 8
- Target Price
- NNNN N/A
- JELD $7.34
- AVG Volume (30 Days)
- NNNN 78.0K
- JELD 1.6M
- Earning Date
- NNNN 01-01-0001
- JELD 08-04-2025
- Dividend Yield
- NNNN N/A
- JELD N/A
- EPS Growth
- NNNN N/A
- JELD N/A
- EPS
- NNNN 0.06
- JELD N/A
- Revenue
- NNNN $8,185,146.00
- JELD $3,592,472,000.00
- Revenue This Year
- NNNN N/A
- JELD N/A
- Revenue Next Year
- NNNN N/A
- JELD $3.40
- P/E Ratio
- NNNN $286.95
- JELD N/A
- Revenue Growth
- NNNN 21.95
- JELD N/A
- 52 Week Low
- NNNN $5.18
- JELD $3.27
- 52 Week High
- NNNN $18.50
- JELD $17.70
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- JELD 39.94
- Support Level
- NNNN N/A
- JELD $3.52
- Resistance Level
- NNNN N/A
- JELD $4.13
- Average True Range (ATR)
- NNNN 0.00
- JELD 0.22
- MACD
- NNNN 0.00
- JELD 0.03
- Stochastic Oscillator
- NNNN 0.00
- JELD 27.66
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.